ReviewMolecules (Basel, Switzerland)2024

Orthoflaviviral Inhibitors in Clinical Trials, Preclinical In Vivo Efficacy Targeting NS2B-NS3 and Cellular Antiviral Activity via Competitive Protease Inhibition.

Lorenzo Cavina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.